Memno peptides, a process for their preparation and their use
CA 2401032 C · Owner: Aventis Pharma Deutschland Gmbh · Inventors: Kogler, Herbert; Schiell, Matthias; Vertesy, Laszlo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to peptide derivatives called memno peptides, of the , formula (I): wherein R1 R2, R3, R4, R5, R6, R7, R8, and (A)n have the meaning herein, obtainable by cultivation of Memnoniella echinata FH2272 DSM 13195 or , mutants and variants of this a process for their preparation and the use of the compounds as pharmaceuticals, for example against cardiac insufficiency.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 15, 2001 and granted April 10, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 15, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 15, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.